Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Issue Open | August 5, 2022 |
| Issue Close | August 19, 2022 |
| Issue Size (Shares) | 6.33 Crores |
| Issue Size (Amount) | ₹37.95 Crores |
| Issue Price | ₹6 per Share |
| Listing At | BSE |
Gennex Laboratories Limited is coming up with Right Issue of the face value of ₹1 each, for an amount of ₹6.33 Crores ('Base Issue Size') with an option to retain oversubscription up to ₹37.95 Crores.
Incorporated in 1995, Gennex Laboratories Limited is Manufacturer of Pharmaceutical Ingredients. The company manufactures products such as Guaifenesin, Methocarbamol, Fluconazole, Mephenesin, Phenazopyridine Hcl, Melitracen Hcl, Flupentixol Di-Hydrochloride, Chlorphenesin, Allopurinol, among other.
The issue opens on Aug 5, 2022 and closes for subscription on Aug 19, 2022. The shares of the company to be list at BSE.
The public issue of Gennex Laboratories Limited opens on Aug 5, 2022 and closes for subscription on Aug 19, 2022.
The Gennex Laboratories Rights Issue 2022 are proposed to list at BSE.
This page provides Rights Issue news of Gennex Laboratories Rights Issue 2022. The Gennex Laboratories Rights Issue 2022 watch offers the latest Rights Issue issue news and keep you updated with the latest Rights Issue news in India.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
